188 related articles for article (PubMed ID: 9921366)
1. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
[No Abstract] [Full Text] [Related]
2. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
Coelho PM; Lima e Silva FC; Nogueira-Machado JA
Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
[TBL] [Abstract][Full Text] [Related]
4. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
Bonesso-Sabadini PI; de Souza Dias LC
Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
[TBL] [Abstract][Full Text] [Related]
5. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine.
Conceição MJ; Argento CA; Corrêa A
Mem Inst Oswaldo Cruz; 2000; 95(3):375-80. PubMed ID: 10800196
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni: chemotherapy of infections of different ages.
Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
8. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
Coelho PM; Mello RT; Gerken SE
Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
[TBL] [Abstract][Full Text] [Related]
10. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
Panic G; Ruf MT; Keiser J
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
13. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
Araujo N; Mattos AC; Coelho PM; Katz N
Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
[TBL] [Abstract][Full Text] [Related]
14. Praziquantel--its use, cost and possible development of resistance.
Kusel J; Hagan P
Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
[No Abstract] [Full Text] [Related]
15. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
Dias LC; Olivier CE
Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
[No Abstract] [Full Text] [Related]
16. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
17. [Behavior of Schistosoma mansoni strain LE, after passage through an accidentally infected human host].
Araújo N; de Souza CP; Dias EP; Katz N
Rev Soc Bras Med Trop; 1986; 19(4):213-8. PubMed ID: 3150588
[No Abstract] [Full Text] [Related]
18. Drug resistance in schistosomiasis: a review.
Bruce JI; Dias LC; Liang YS; Coles GC
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():143-50. PubMed ID: 3151088
[TBL] [Abstract][Full Text] [Related]
19. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
[No Abstract] [Full Text] [Related]
20. Immunosuppression and parasitic diseases: experimental Schistosomiasis mansoni.
Gargione C; Vellosa SA; Hoshino-Shimizu S; Okumura M; Chiodelle SG
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(3):122-8. PubMed ID: 10436644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
